JD Esq - Impact BioMedical, Chairman CEO
| IBO Stock | USD 1.85 0.08 4.15% |
Chairman
JD Esq is Chairman CEO of Impact BioMedical,
| Age | 69 |
| Address | 1400 Broadfield Blvd., Houston, TX, United States, 77084 |
| Phone | 585-325-3610 |
| Web | https://www.impactbiomedinc.com |
Impact BioMedical, Management Efficiency
The company has Return on Asset of (0.0499) % which means that on every $100 spent on assets, it lost $0.0499. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0345 %, implying that it generated $0.0345 on every 100 dollars invested. Impact BioMedical,'s management efficiency ratios could be used to measure how well Impact BioMedical, manages its routine affairs as well as how well it operates its assets and liabilities. As of the 8th of January 2025, Return On Capital Employed is likely to grow to 0.11, while Return On Tangible Assets are likely to drop (2.01). As of the 8th of January 2025, Other Current Assets is likely to grow to about 125.6 K, while Total Assets are likely to drop about 39.1 M.Similar Executives
| Found 1 records | CHAIRMAN Age | ||
| Robert Bilkie | Eagle Capital Growth | 58 | |
Management Performance
| Return On Equity | 0.0345 | ||||
| Return On Asset | -0.0499 |
Impact BioMedical, Leadership Team
Elected by the shareholders, the Impact BioMedical,'s board of directors comprises two types of representatives: Impact BioMedical, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Impact. The board's role is to monitor Impact BioMedical,'s management team and ensure that shareholders' interests are well served. Impact BioMedical,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Impact BioMedical,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Todd Macko, C Treasurer | ||
| Todd CPA, C Treasurer | ||
| JD Esq, Chairman CEO | ||
| Mark Suseck, Chief Officer |
Impact Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Impact BioMedical, a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0345 | ||||
| Return On Asset | -0.0499 | ||||
| Current Valuation | 25.3 M | ||||
| Shares Outstanding | 11.5 M | ||||
| Shares Owned By Insiders | 55.16 % | ||||
| Shares Owned By Institutions | 1.41 % | ||||
| Number Of Shares Shorted | 1.05 K | ||||
| Price To Book | 0.64 X | ||||
| EBITDA | (2.82 M) | ||||
| Net Income | (4.34 M) |
Pair Trading with Impact BioMedical,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Impact BioMedical, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Impact BioMedical, will appreciate offsetting losses from the drop in the long position's value.Moving against Impact Stock
| 0.57 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.55 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.52 | LLY | Eli Lilly | PairCorr |
The ability to find closely correlated positions to Impact BioMedical, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Impact BioMedical, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Impact BioMedical, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Impact BioMedical, to buy it.
The correlation of Impact BioMedical, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Impact BioMedical, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Impact BioMedical, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Impact BioMedical, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical,. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical, is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical,'s value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical,'s market value can be influenced by many factors that don't directly affect Impact BioMedical,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.